Overall Survival Benefit With Lapatinib in Combination With Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Final Results From the EGF104900 Study
Blackwell, K. L., Burstein, H. J., Storniolo, A. M., Rugo, H. S., Sledge, G., Aktan, G., Ellis, C., Florance, A., Vukelja, S., Bischoff, J., Baselga, J., O'Shaughnessy, J.Volume:
30
Language:
english
Pages:
8
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2011.35.6725
Date:
July, 2012
File:
PDF, 203 KB
english, 2012